Astrana Health Stock Gross Profit
Astrana Health fundamentals help investors to digest information that contributes to Astrana Health's financial success or failures. It also enables traders to predict the movement of Astrana Stock. The fundamental analysis module provides a way to measure Astrana Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Astrana Health stock.
Astrana |
Astrana Health Company Gross Profit Analysis
Astrana Health's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Astrana Health Gross Profit | 199.48 M |
Most of Astrana Health's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Astrana Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Astrana Health reported 199.48 M of gross profit. This is 91.11% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The gross profit for all United States stocks is 99.27% higher than that of the company.
Astrana Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astrana Health's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Astrana Health could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics of similar companies.Astrana Health is currently under evaluation in gross profit category among its peers.
Astrana Fundamentals
| Return On Equity | 0.0976 | |||
| Return On Asset | 0.0626 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.81 B | |||
| Shares Outstanding | 45.45 M | |||
| Shares Owned By Insiders | 25.77 % | |||
| Shares Owned By Institutions | 46.99 % | |||
| Number Of Shares Shorted | 2.75 M | |||
| Price To Earning | 28.18 X | |||
| Price To Book | 3.12 X | |||
| Price To Sales | 1.40 X | |||
| Revenue | 1.33 B | |||
| Gross Profit | 199.48 M | |||
| EBITDA | 117.97 M | |||
| Net Income | 48.51 M | |||
| Cash And Equivalents | 273.71 M | |||
| Cash Per Share | 6.04 X | |||
| Total Debt | 229.36 M | |||
| Debt To Equity | 0.42 % | |||
| Current Ratio | 2.49 X | |||
| Book Value Per Share | 12.74 X | |||
| Cash Flow From Operations | 133.87 M | |||
| Short Ratio | 17.16 X | |||
| Earnings Per Share | 1.04 X | |||
| Target Price | 46.56 | |||
| Number Of Employees | 1.36 K | |||
| Beta | 1.04 | |||
| Market Capitalization | 1.86 B | |||
| Total Asset | 966.21 M | |||
| Retained Earnings | 192.68 M | |||
| Working Capital | 287.81 M | |||
| Current Asset | 13.56 M | |||
| Current Liabilities | 7.43 M | |||
| Z Score | 7.27 | |||
| Net Asset | 966.21 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Astrana Stock
If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |